New York, Global Influenza Diagnostics Market was valued at USD 0.9 billion in 2021 and it is anticipated to grow further till USD 1.6 billion by 2031, at a CAGR of 5.9% during the forecast period.
The global influenza diagnostics market report from Global Insight Services is the single authoritative source of intelligence on Influenza Diagnostics Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
The influenza virus is the infectious disease that causes influenza, also referred to as “the flu.” Flu is identified and diagnosed using a variety of conventional and molecular diagnostic tools. Modern technology is able to diagnose influenza quite effectively and precisely. For instance, the real-time molecular test known as the reverse transcription-polymerase chain reaction (RT-PCR) allows for the identification of influenza genetic material. Furthermore, due of its quick results and simple specimen collection, rapid influenza diagnostic testing (RIDT) has become an efficient approach for diagnosis.
Request sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10306/
Market Trends and Drivers
R&D efforts for better detection and diagnosis of influenza have intensified due to its rising frequency globally. The majority of research efforts concentrate on creating quicker and more precise diagnostic tools for influenza viruses, which will spur market expansion. Similarly, Numerous assays and technologies helpful for the diagnosis and treatment of influenza infections have been developed as a result of the enormous quantity of data produced by the Human Genome Project and developments in molecular and biomedical technologies. These new genomic and proteomic technologies, such as microarray-based detection and PCR-based approaches, aid in the identification of novel influenza viruses. Additionally, they allow for quicker and better surveillance of infectious diseases, which presents a business opportunity.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10306/
Global Influenza Diagnostics Market Segmental Overview
The report analyses the global influenza diagnostics market based on the product, test type, end user, and region.
Global Influenza Diagnostics Market by Product
Based on the product, it is segmented into test kit & reagent, instrument, and other products. In 2021, the test kit & reagent segment accounted for the largest share of the influenza diagnostic market. The increasing prevalence of influenza coupled with the growing demand for rapid disease diagnosis are boosting the growth of the market.
Global Influenza Diagnostics Market by Test Type
Based on the test type, it is segmented into molecular diagnostic tests and traditional diagnostic tests. In 2021, the molecular diagnostic tests segment accounted for the largest share of the influenza diagnostics market. The various factors such as growth in influenza research for diagnostic technologies coupled with increasing prevalence of influenza is anticipated to drive the market.
Global Influenza Diagnostics Market by End User
Based on the end user, it is segmented into diagnostic laboratories, hospitals & clinics, and other end users. In 2021, diagnostic laboratories segment is accounted for largest share in the influenza diagnostic market. The increasing prevalence of influenza coupled with rising demand for rapid disease diagnosis is boosting the growth of the segment.
Geographical Analysis of the Global Influenza Diagnostics Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the global influenza diagnostics market. The North American influenza diagnostics markets growth is primarily attributed to the growth in influenza research for diagnostic technologies and increasing prevalence of influenza.
Major Players in the Global Influenza Diagnostics Market
The key players in the market are Danaher Corporation (US), Siemens Healthineers (Germany), Thermo Fisher Scientific, Inc. (US), F. Hoffmann-LA Roche AG (Switzerland), Abbott Laboratories, Inc. (US), Hologic, Inc. (US), bioMérieux SA (France), Quidel Corporation (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), GenMark Diagnostics, Inc. (US), Luminex Corporation (US), Tecan Trading AG (Switzerland), DiaSorin SA (Italy), and altona Diagnostics GmbH (Germany) among others.
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10306/
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700